×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
S28 : The Ideal State of Clinical Trials in Japan and the Creation of a Clinical Trial Ecosystem through the Implementation of DCT in the Oncology Field
Session Chair(s)
Takuma Matsunaga
Business Producer, DCT Unit
MICIN, Inc., Japan
Mami Takahashi
Clinical IT Solution Architect, Clinical System and Informatics Group,
Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
Takafumi Koyama
National Cancer Center Hospital, Japan
Head of Physicians, Department of Experimental Therapeutics
Hiroya Taniguchi, MD
Aichi Cancer Center Hospital, Japan
Head Physician, Department of Clinical Oncology
Kanako Saito
Eli Lilly Japan K.K., Japan
Associate Director, Clinical Lead, Clinical Development
Yuji Minami
Takeda Pharmaceutical Company Limited, Japan
Associate Director,Development Operations Excellence
Tomokazu Handa
Janssen Pharmaceutical K.K., Japan
Trial Lead Department, Manager